Antti Virkamäki

3.9k total citations · 2 hit papers
33 papers, 3.0k citations indexed

About

Antti Virkamäki is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Antti Virkamäki has authored 33 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Physiology. Recurrent topics in Antti Virkamäki's work include Pancreatic function and diabetes (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Muscle metabolism and nutrition (5 papers). Antti Virkamäki is often cited by papers focused on Pancreatic function and diabetes (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Muscle metabolism and nutrition (5 papers). Antti Virkamäki collaborates with scholars based in Finland, United States and Sweden. Antti Virkamäki's co-authors include Kohjiro Ueki, Hannele Yki‐Järvinen, Satu Vehkavaara, C. Ronald Kahn, Franck Mauvais‐Jarvis, Ariel Zisman, Donald A. McClain, Marc C. Daniels, Odile D. Peroni and Laurie J. Goodyear and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Antti Virkamäki

33 papers receiving 2.9k citations

Hit Papers

Protein–protein interaction in insulin signaling and the ... 1999 2026 2008 2017 1999 2000 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
    1999 661 citations Antti Virkamäki, Kohjiro Ueki et al. Journal of Clinical Investigation profile →
  2. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance
    2000 612 citations Ariel Zisman, Odile D. Peroni et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antti Virkamäki Finland 24 1.5k 858 741 626 392 33 3.0k
Hiroki Fujita Japan 30 1.2k 0.8× 624 0.7× 852 1.1× 543 0.9× 407 1.0× 103 3.7k
Sven Schinner Germany 27 1.3k 0.8× 578 0.7× 789 1.1× 539 0.9× 381 1.0× 94 2.7k
Michael Bryer‐Ash United States 29 947 0.6× 602 0.7× 975 1.3× 553 0.9× 608 1.6× 59 3.0k
Satoshi Ugi Japan 35 1.9k 1.3× 939 1.1× 552 0.7× 504 0.8× 642 1.6× 110 3.5k
Junta Imai Japan 31 974 0.7× 711 0.8× 522 0.7× 807 1.3× 602 1.5× 82 2.8k
Bernard Desbuquois France 23 1.4k 0.9× 557 0.6× 838 1.1× 730 1.2× 227 0.6× 74 2.7k
Ralph Rabkin United States 29 1.2k 0.8× 708 0.8× 988 1.3× 587 0.9× 191 0.5× 142 3.3k
Ko Kotani Japan 18 2.4k 1.6× 1.3k 1.5× 455 0.6× 729 1.2× 932 2.4× 24 3.8k
Yasushi Fukushima Japan 43 2.6k 1.8× 1.0k 1.2× 636 0.9× 822 1.3× 746 1.9× 106 4.8k
Hadi Al‐Hasani Germany 38 2.2k 1.5× 1.2k 1.4× 551 0.7× 959 1.5× 551 1.4× 138 4.2k

Countries citing papers authored by Antti Virkamäki

Since Specialization
Citations

This map shows the geographic impact of Antti Virkamäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antti Virkamäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antti Virkamäki more than expected).

Fields of papers citing papers by Antti Virkamäki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antti Virkamäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antti Virkamäki. The network helps show where Antti Virkamäki may publish in the future.

Co-authorship network of co-authors of Antti Virkamäki

This figure shows the co-authorship network connecting the top 25 collaborators of Antti Virkamäki. A scholar is included among the top collaborators of Antti Virkamäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antti Virkamäki. Antti Virkamäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varis, Juha, Kaj Metsärinne, Veikko A Koivisto, et al.. (2016). Improved control of blood pressure and albuminuria among patients with type-2 diabetes in Finnish open care. Blood Pressure. 26(2). 67–73. 1 indexed citations
2.
Metsärinne, Kaj, Anders Bröijersén, Ilkka Kantola, et al.. (2014). High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care. Primary care diabetes. 9(1). 31–38. 38 indexed citations
3.
Pirinen, Eija, Esa Hohtola, Jussi Paananen, et al.. (2011). The activation of hepatic and muscle polyamine catabolism improves glucose homeostasis. Amino Acids. 42(2-3). 427–440. 18 indexed citations
4.
Sreenan, Séamus, et al.. (2008). Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE™ study. International Journal of Clinical Practice. 62(12). 1971–1980. 21 indexed citations
5.
Harjola, Veli‐Pekka, et al.. (2006). The effect of moderate exercise training on skeletal muscle myosin heavy chain distribution in chronic heart failure. International Journal of Cardiology. 109(3). 335–338. 6 indexed citations
6.
Sutinen, Jussi, Katja Kannisto, Elena Korsheninnikova, et al.. (2004). Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology-Endocrinology and Metabolism. 286(6). E941–E949. 45 indexed citations
7.
Zhang, Zhiquan, et al.. (2004). Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: Involvement in diabetic teratogenesis. Birth Defects Research Part A Clinical and Molecular Teratology. 70(8). 519–527. 75 indexed citations
8.
9.
Vehkavaara, Satu, Tiina Hakala‐Ala‐Pietilä, Antti Virkamäki, et al.. (2000). Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women. Circulation. 102(22). 2687–2693. 94 indexed citations
10.
Zisman, Ariel, Odile D. Peroni, E. Dale Abel, et al.. (2000). Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nature Medicine. 6(8). 924–928. 612 indexed citations breakdown →
11.
Vehkavaara, Satu, Jukka Westerbacka, Tiina Hakala‐Ala‐Pietilä, et al.. (2000). Effect of Estrogen Replacement Therapy on Insulin Sensitivity of Glucose Metabolism and Preresistance and Resistance Vessel Function in Healthy Postmenopausal Women1. The Journal of Clinical Endocrinology & Metabolism. 85(12). 4663–4670. 37 indexed citations
12.
Yki-Järvinen, H, Tuulikki Nyman, Eeva Rissanen, et al.. (1999). Glutamine: Fructose-6-phosphate amidotransferase activity and gene expression are regulated in a tissue-specific fashion in pregnant rats. Life Sciences. 65(2). 215–223. 11 indexed citations
13.
14.
Mäkimattila, Sari, Jukka Luoma, Seppo Ylä‐Herttuala, et al.. (1999). Autoantibodies against oxidized LDL and endothelium-dependent vasodilation in insulin-dependent diabetes mellitus. Atherosclerosis. 147(1). 115–122. 16 indexed citations
15.
Virkamäki, Antti, et al.. (1999). Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. Journal of Clinical Investigation. 103(7). 931–943. 661 indexed citations breakdown →
16.
Yki‐Järvinen, Hannele, Antti Virkamäki, Marc C. Daniels, Donald A. McClain, & William Gottschalk. (1998). Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism. 47(4). 449–455. 97 indexed citations
17.
Virkamäki, Antti, Marc C. Daniels, Sari Hämäläinen, et al.. (1997). Activation of the Hexosamine Pathway by Glucosaminein VivoInduces Insulin Resistance in Multiple Insulin Sensitive Tissues1. Endocrinology. 138(6). 2501–2507. 82 indexed citations
18.
Utriainen, Tapio, Sari Mäkimattila, Antti Virkamäki, Robert Bergholm, & Hannele Yki‐Järvinen. (1996). Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia. 39(12). 1477–1482. 42 indexed citations
19.
Utriainen, Tapio, Sari Mäkimattila, Antti Virkamäki, et al.. (1996). Physical fitness and endothelial function (nitric oxide synthesis) are independent determinants of insulin-stimulated blood flow in normal subjects.. The Journal of Clinical Endocrinology & Metabolism. 81(12). 4258–4263. 25 indexed citations
20.
Panula, Pertti, Olli Häppölä, Matti S. Airaksinen, S. Auvinen, & Antti Virkamäki. (1988). Carbodiimide as a tissue fixative in histamine immunohistochemistry and its application in developmental neurobiology.. Journal of Histochemistry & Cytochemistry. 36(3). 259–269. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Fujita Breakdown of academic impact, for papers by Sven Schinner Breakdown of academic impact, for papers by Michael Bryer‐Ash Breakdown of academic impact, for papers by Satoshi Ugi Breakdown of academic impact, for papers by Junta Imai Breakdown of academic impact, for papers by Bernard Desbuquois Breakdown of academic impact, for papers by Ralph Rabkin Breakdown of academic impact, for papers by Ko Kotani Breakdown of academic impact, for papers by Yasushi Fukushima Breakdown of academic impact, for papers by Hadi Al‐Hasani
Rankless by CCL
2026